Transforming body composition with semaglutide in adults with obesity and type 2 diabetes mellitus.

Front Endocrinol (Lausanne) · 2024 · PMC11182984 · PMID 38894744

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may not be significantno p-value reported

This suggests that there may not be significant differences between the two administration forms.

also in 2,774 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.